News-Medical.Net January 13, 2026
The Lancet

Most COVID-19 vaccine hesitancy is rooted in concerns that can be addressed and effectively reduced over time, according to a new study following more than 1.1 million people in England between January 2021 and March 2022 during the COVID-19 pandemic, published in The Lancet.

The study, led by researchers from Imperial College London, found that of the participants initially hesitant about getting a COVID-19 vaccine, 65% went on to get vaccinated at least once.

The findings offer a novel perspective on the main types of vaccine hesitancy during the COVID-19 pandemic. Their potential to be reversed may help inform the targeting and messaging for future roll-outs of novel vaccines.

While vaccine hesitancy is not a new phenomenon, with WHO naming...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Govt Agencies, Healthcare System, HHS, Patient / Consumer, Provider, Public Health / COVID, Survey / Study, Trends
Charted: Where measles is surging (again)
Remembering A Global Health Hero
AAP Releases 2026 Child Vax Schedule, No Longer Endorses CDC's Version
Opinion: Our podcast ‘Why Should I Trust You?’ connects MAHA and public health. Here’s what we’ve learned
Lessons From William H. Foege, A Global Health Legend

Share Article